Xeris Biopharma Holdings (XERS) Exchange Rate Effect (2020 - 2022)
Xeris Biopharma Holdings (XERS) posted Exchange Rate Effect of $1000.0 for Q3 2022, up 200.0% on a QoQ basis from -$1000.0 in Q1 2022, and up 150.0% year-over-year from $400.0 in Q3 2021.
Xeris Biopharma Holdings (XERS) Exchange Rate Effect (2020 - 2022) Analysis & Trends
Xeris Biopharma Holdings' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at $1000.0 for Q3 2022.
- Quarterly Exchange Rate Effect rose 150.0% year-over-year to $1000.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $1000.0 (up 120.0% YoY) and the FY2021 annual result came in at -$3000.0, up 86.36% from the prior year.
- Exchange Rate Effect was $1000.0 for Q3 2022 at Xeris Biopharma Holdings, up from -$1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $6000.0 in Q4 2020 and bottomed at -$2000.0 in Q3 2021.
- A 3-year average of $500.0 and a median of $0.0 in 2021 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect slumped 133.33% — and 2022, when it soared 150.0%.
- Xeris Biopharma Holdings' Exchange Rate Effect stood at $6000.0 in 2020, then tumbled by 133.33% to -$2000.0 in 2021, then surged by 150.0% to $1000.0 in 2022.
- Business Quant data shows XERS's Exchange Rate Effect at $1000.0 in Q3 2022, -$1000.0 in Q1 2022, and -$2000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Xeris Biopharma Holdings | 1.43 Bn | 1.32 Bn | 72.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |